These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35190817)

  • 21. Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader.
    Kabir M; Qin L; Luo K; Xiong Y; Sidi RA; Park KS; Jin J
    J Med Chem; 2024 Apr; 67(8):6880-6892. PubMed ID: 38607318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory.
    Song T; Liang S; Liu J; Zhang T; Yin Y; Geng C; Gao S; Feng Y; Xu H; Guo D; Roberts A; Gu Y; Cang Y
    PLoS Genet; 2018 Jan; 14(1):e1007165. PubMed ID: 29370161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term depletion of cereblon induces mitochondrial dysfunction in cancer cells.
    Park S; Kim K; Haam K; Ban HS; Kim JA; Park BC; Park SG; Kim S; Kim JH
    BMB Rep; 2021 Jun; 54(6):305-310. PubMed ID: 33408001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UBE2G1 governs the destruction of cereblon neomorphic substrates.
    Lu G; Weng S; Matyskiela M; Zheng X; Fang W; Wood S; Surka C; Mizukoshi R; Lu CC; Mendy D; Jang IS; Wang K; Marella M; Couto S; Cathers B; Carmichael J; Chamberlain P; Rolfe M
    Elife; 2018 Sep; 7():. PubMed ID: 30234487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalidomide and its metabolite 5-hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF.
    Yamanaka S; Murai H; Saito D; Abe G; Tokunaga E; Iwasaki T; Takahashi H; Takeda H; Suzuki T; Shibata N; Tamura K; Sawasaki T
    EMBO J; 2021 Feb; 40(4):e105375. PubMed ID: 33470442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. USP15 antagonizes CRL4
    Nguyen TV
    Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34583995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cereblon Regulates the Proteotoxicity of Tau by Tuning the Chaperone Activity of DNAJA1.
    Akber U; Jo H; Jeon S; Yang SJ; Bong S; Lim S; Kim YK; Park ZY; Park CS
    J Neurosci; 2021 Jun; 41(24):5138-5156. PubMed ID: 33972400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crbn modulates calcium influx by regulating Orai1 during efferocytosis.
    Moon H; Min C; Kim G; Kim D; Kim K; Lee SA; Moon B; Yang S; Lee J; Yang SJ; Cho SK; Lee G; Lee CS; Park CS; Park D
    Nat Commun; 2020 Oct; 11(1):5489. PubMed ID: 33127885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases.
    Zhou L; Xu G
    J Mol Biol; 2022 Mar; 434(5):167457. PubMed ID: 35045330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of pentylenetetrazole-induced seizures in mice with Cereblon gene knockout.
    Jeon SJ; Ham J; Park CS; Lee B
    BMB Rep; 2020 Sep; 53(9):484-489. PubMed ID: 32843131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRBN Is a Negative Regulator of Bactericidal Activity and Autophagy Activation Through Inhibiting the Ubiquitination of ECSIT and BECN1.
    Kim MJ; Min Y; Shim JH; Chun E; Lee KY
    Front Immunol; 2019; 10():2203. PubMed ID: 31620128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cereblon: promise and challenges for combating human diseases.
    Kim HK; Seol JE; Ahn SW; Jeon S; Park CS; Han J
    Pflugers Arch; 2021 Nov; 473(11):1695-1711. PubMed ID: 34553266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a lenalidomide-sensitive syngeneic murine in vivo multiple myeloma model by expression of Crbn
    Röhner L; Ng YLD; Scheffold A; Lindner S; Köpff S; Brandl A; Beilhack A; Krönke J
    Exp Hematol; 2021 Jan; 93():61-69.e4. PubMed ID: 33186626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cereblon attenuates DNA damage-induced apoptosis by regulating the transcription-independent function of p53.
    Zhou L; Xu G
    Cell Death Dis; 2019 Jan; 10(2):69. PubMed ID: 30683842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.
    Bai N; Riching KM; Makaju A; Wu H; Acker TM; Ou SC; Zhang Y; Shen X; Bulloch DN; Rui H; Gibson BW; Daniels DL; Urh M; Rock BM; Humphreys SC
    J Biol Chem; 2022 Apr; 298(4):101653. PubMed ID: 35101445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interacting domains in cereblon differentially modulate the immunomodulatory drug-mediated ubiquitination and degradation of its binding partners.
    Tao J; Yang J; Xu G
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):443-449. PubMed ID: 30458989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advancing targeted protein degrader discovery by measuring cereblon engagement in cells.
    Zerfas BL; Huerta F; Liu H; Du G; Gray NS; Jones LH; Nowak RP
    Methods Enzymol; 2023; 681():169-188. PubMed ID: 36764756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN.
    Sievers QL; Petzold G; Bunker RD; Renneville A; Słabicki M; Liddicoat BJ; Abdulrahman W; Mikkelsen T; Ebert BL; Thomä NH
    Science; 2018 Nov; 362(6414):. PubMed ID: 30385546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase.
    Matyskiela ME; Lu G; Ito T; Pagarigan B; Lu CC; Miller K; Fang W; Wang NY; Nguyen D; Houston J; Carmel G; Tran T; Riley M; Nosaka L; Lander GC; Gaidarova S; Xu S; Ruchelman AL; Handa H; Carmichael J; Daniel TO; Cathers BE; Lopez-Girona A; Chamberlain PP
    Nature; 2016 Jul; 535(7611):252-7. PubMed ID: 27338790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity.
    Liu J; Song T; Zhou W; Xing L; Wang S; Ho M; Peng Z; Tai YT; Hideshima T; Anderson KC; Cang Y
    Leukemia; 2019 Jan; 33(1):171-180. PubMed ID: 30026574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.